Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2

被引:54
作者
Dihal, Ashwin A.
Woutersen, Ruud A.
Van Ommen, Ben
Rietjens, Ivonne M. C. M.
Stierum, Rob H.
机构
[1] TNO, Qual Life, Dept Physiol Sci, NL-3700 AJ Zeist, Netherlands
[2] TNO, Qual Life, Dept Toxicol & Appl Pharmacol, NL-3700 AJ Zeist, Netherlands
[3] Univ Wageningen & Res Ctr, Div Toxicol, Wageningen, Netherlands
关键词
quercetin; proliferation; differentiation; metabolism; colorectal cancer; Caco-2;
D O I
10.1016/j.canlet.2005.07.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of the dietary flavonoid quercetin was investigated on proliferation and differentiation of the human colon cancer cell line Caco-2. Confluent Caco-2 monolayers exposed to quercetin showed a biphasic effect on cell proliferation and a decrease in cell differentiation (0.001 < P < 0.05). During differentiation Caco-2 cells formed 5 phase II metabolites, of which the amount of 4'-O-methyl-quercetin-3'-O-glucuronide correlated with the differentiation grade (r = 0.99, P < 0.003). The increment of cell proliferation at low quercetin concentrations and the decrease in cell differentiation are effects opposite to what would be expected for a functional food ingredient with anti-carcinogenic potential. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:248 / 259
页数:12
相关论文
共 53 条
[41]   Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2 [J].
Stierum, R ;
Gaspari, M ;
Dommels, Y ;
Ouatas, T ;
Pluk, H ;
Jespersen, S ;
Vogels, J ;
Verhoeckx, K ;
Groten, J ;
van Ommen, B .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2003, 1650 (1-2) :73-91
[42]  
Tanaka T, 1999, ONCOL REP, V6, P1333
[43]  
TIETZ NW, 1983, CLIN CHIM ACTA, V135, P339
[44]   Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems [J].
van der Woude, H ;
Boersma, MG ;
Vervoort, J ;
Rietjens, IMCM .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (11) :1520-1530
[45]   Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans [J].
van der Woude, H ;
Gliszczynska-Swiglo, A ;
Struijs, K ;
Smeets, A ;
Alink, GM ;
Rietjens, IMCM .
CANCER LETTERS, 2003, 200 (01) :41-47
[46]   Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro [J].
van Erk, MJ ;
Roepman, P ;
van der Lende, TR ;
Stierum, RH ;
Aarts, JMMJG ;
van Bladeren, PJ ;
van Ommen, B .
EUROPEAN JOURNAL OF NUTRITION, 2005, 44 (03) :143-156
[47]   HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2 [J].
Wächtershäuser, A ;
Akoglu, B ;
Stein, J .
CARCINOGENESIS, 2001, 22 (07) :1061-1067
[48]   Quercetin, an over-the-counter supplement, causes neuroblastoma-like elevation of plasma homovanillic acid [J].
Weldin, J ;
Jack, R ;
Dugaw, K ;
Kapur, RP .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2003, 6 (06) :547-551
[49]  
Wenzel H, 2000, CANCER RES, V60, P3823
[50]   Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells [J].
Wenzel, U ;
Herzog, A ;
Kuntz, S ;
Daniel, H .
PROTEOMICS, 2004, 4 (07) :2160-2174